Matthew Hesh sat at the long conference table in the White House situation room, surrounded by advisors, scientists, and military personnel. The telegraph operator read aloud the latest message from Dr. Hall in Chicago: "Patient's condition steadily improving. Second dose administered. Continuing close monitoring."
The room fell silent for a moment. Everyone processed the significance of the report. This was the first real sign that the experimental treatment might be working. Relief washed over the room, but Matthew remained cautious.
"Improvement is good," he said, breaking the silence. "But it's just one case. We need a broader set of data. Start preparing other hospitals to begin controlled trials. Coordinate with governors to establish secure transportation for supplies and medical personnel."
Henry Collins, Matthew's Chief of Staff, nodded and jotted down notes. "Understood, Mr. President. We'll contact the necessary authorities immediately."
